Cargando…
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
The development of clinical practice recommendations or guidelines for the clinical use of biomarkers is an issue of great importance with regard to adverse drug reactions. The potential of pharmacogenomic biomarkers has been extensively investigated in recent years. However, several barriers to imp...
Autores principales: | Agúndez, José A. G., Abad-Santos, Francisco, Aldea, Ana, Alonso-Navarro, Hortensia, Bernal, María L., Borobia, Alberto M., Borrás, Emma, Carballo, Miguel, Carvajal, Alfonso, García-Muñiz, José D., Gervasini, Guillermo, Jiménez-Jiménez, Félix J., Lucena, María I., Martínez, Carmen, Sacristán, José A., Salado, Inés, Sinués, Blanca, Vicente, Jorge, García-Martín, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516180/ https://www.ncbi.nlm.nih.gov/pubmed/23233861 http://dx.doi.org/10.3389/fgene.2012.00273 |
Ejemplares similares
-
Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue
por: Agúndez, José A. G., et al.
Publicado: (2014) -
Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
por: Agúndez, José A. G., et al.
Publicado: (2014) -
Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
por: Borràs, Emma, et al.
Publicado: (2011) -
Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022) -
Pharmacogenomics of Prostaglandin and Leukotriene Receptors
por: Cornejo-García, José A., et al.
Publicado: (2016)